Hologic to Acquire Mobidiag for ~ $795M

 Hologic to Acquire Mobidiag for ~ $795M

Hologic to Acquire Mobidiag for ~ $795M

Shots:

  • Hologic to acquire Mobidiag for ~$795M which includes ~$714M in cash for Mobidiag’s equity and debt of $81M. The acquisition is expected to close in Q4’21
  • The acquisition will accelerate Hologic’s global footprints by enabling it to expand into the large, fast-growing acute care adjacency with a near-patient testing solution that offers ease of use, multiplex capability and rapid turnaround time
  • Mobidiag offers a broad range of tests and automated platforms including Amplidiag and Novodiag. Additionally, Hologic plans to invest in assay development to promote the growth of the Novodiag platform

Click here to­ read full press release/ article | Ref: BusinessWire | Image: Medical Product Outsourcing

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post